World's Best Scientists 2026 revealed!
Fumio Imazeki

Fumio Imazeki

D-Index & Metrics

Microbiology

D-Index
63
Citations
13718
World Ranking
2737
National Ranking
101

Fumio Imazeki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Fumio Imazeki sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 296 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Fumio Imazeki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Fumio Imazeki sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Fumio Imazeki is affiliated with Chiba University in Japan and specializes in medical research with a focus on several subfields including epidemiology, hepatology, pulmonary and respiratory medicine, oncology, and health toxicology and mutagenesis. Their research contributions span various aspects of liver diseases, viral infections, and public health impacts related to infectious diseases and environmental factors.

The main areas of study for Imazeki include medicine, with five publications contributing to this field. The specific subfields represented in their work are:

  • Epidemiology (2 publications)
  • Hepatology (1 publication)
  • Pulmonary and Respiratory Medicine (1 publication)
  • Oncology (1 publication)
  • Health, Toxicology and Mutagenesis (1 publication)

Their research topics cover a range of subjects related to infectious diseases, liver disease, and healthcare impacts, as follows:

  • Hepatitis B Virus Studies (2 publications)
  • Hepatitis C Virus Research (2 publications)
  • Liver Disease Diagnosis and Treatment (2 publications)
  • Infection Control and Ventilation (2 publications)
  • COVID-19 and Healthcare Impacts (2 publications)
  • Climate Change and Health Impacts (2 publications)

Recent publications by Fumio Imazeki include:

  • "Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan," 2022, published in the Journal of Gastroenterology
  • "Practical approach to prevent COVID-19 infection at breast cancer screening," 2021, published in Breast Cancer

Their frequent co-authors comprise:

  • Kazumasa Sakamoto
  • Kiyoaki Ito
  • Hiroshi Yotsuyanagi
  • Hiroshi Yatsuhashi
  • Yasuhito Tanaka

Fumio Imazeki's publications have appeared primarily in the following venues:

  • Journal of Gastroenterology
  • Breast Cancer

Best Publications

  • Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

    Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa

  • Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

    Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano

  • Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

    Hajime Sumi;Osamu Yokosuka;Naohiko Seki;Makoto Arai

  • Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients

    Susumu Takano;Osamu Yokosuka;Fumio Imazeki;Masami Tagawa

  • Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival

    Yasushi Shiratori;Yoichi Ito;Osamu Yokosuka;Fumio Imazeki

  • Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

    Y Shiratori;N Kato;O Yokosuka;F Imazeki

  • Resolution of acute hepatitis C after therapy with natural beta interferon.

    M. Omata;O. Yokosuka;S. Takano;N. Kato

  • Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease

    Hiroshige Kojima;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho

  • Bezafibrate treatment: a new medical approach for PBC patients?

    Tatsuo Kanda;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho

  • Precore mutations and core clustering mutations in chronic hepatitis B virus infection

    Wan-Long Chuang;Masao Omata;Toshiki Ehata;Osamu Yokosuka

  • High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease

    F Tanaka;Y Shiratori;O Yokosuka;F Imazeki

  • Heterogeneity and evolution rates of delta virus RNA sequences.

    F Imazeki;M Omata;M Ohto

  • New antiviral therapies for chronic hepatitis C.

    Tatsuo Kanda;Fumio Imazeki;Osamu Yokosuka

  • Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA

    Osamu Yokosuka;Osamu Yokosuka;Masao Omata;Masao Omata;Fumio Imazeki;Fumio Imazeki;Kunio Okuda;Kunio Okuda

  • Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients

    Fumio Imazeki;Osamu Yokosuka;Kenichi Fukai;Tatsuo Kanda

  • Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma.

    Motohisa Tada;Fumihiko Kanai;Yasuo Tanaka;Keisuke Tateishi

  • Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

    Fumio Imazeki;Osamu Yokosuka;Kenichi Fukai;Hiromitsu Saisho

  • Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan.

    T Imamura;O Yokosuka;T Kurihara;T Kanda

  • Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.

    Tetsuhiro Chiba;Osamu Yokosuka;Kenichi Fukai;Hiroshige Kojima

  • Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells

    Tetsuhiro Chiba;Osamu Yokosuka;Makoto Arai;Motohisa Tada

  • Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis

    Keiichi Fujiwara;Osamu Yokosuka;Kenichi Fukai;Fumio Imazeki

  • 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells

    Tetsuhiro Chiba;Eiichiro Suzuki;Masamitsu Negishi;Atsunori Saraya

Frequent Co-Authors

Osamu Yokosuka
Osamu Yokosuka Chiba University
Hiromitsu Saisho
Hiromitsu Saisho Chiba University
Masao Omata
Masao Omata University of Tokyo
Kunio Okuda
Kunio Okuda Chiba University
Yasushi Shiratori
Yasushi Shiratori Okayama University
Michio Sata
Michio Sata Kurume University
Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Haruhiko Yoshida
Haruhiko Yoshida University of Tokyo
Eiji Tanaka
Eiji Tanaka Shinshu University
Naohiko Seki
Naohiko Seki Chiba University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related career paths, especially within healthcare and information management. For those interested in combining clinical knowledge with holistic health approaches, exploring how to become a functional medicine nurse practitioner can be a rewarding option. This role blends medical expertise with alternative practices to improve patient outcomes.

On the administrative side, expertise in medical coding and health information is increasingly valuable. Certification like the cpc certification salary highlights the earning potential and career growth possible in professional coding, which supports accurate medical billing and data management.

Those interested in managing healthcare data might consider careers in health information management. The health information management salary entry-level provides insight into starting salaries and growth opportunities in this vital field.

To help prepare for these roles, pursuing the best online health information management degree cahiim accredited can offer a flexible and reputable pathway. This accreditation ensures programs meet industry standards, making graduates more competitive in the job market.

Best Scientists Citing Fumio Imazeki

Trending Scientists

Recently Published Articles